The Biden administration released its next round of prescription drugs selected for Medicare price negotiations, including Ozempic — the blockbuster diabetes drug that’s also used for weight loss.

The list, which includes 15 drugs, up from 10 last year, marks the first step in a negotiation process between Medicare and drugmakers that is expected to take place over the coming months. The new negotiated prices will take effect in 2027.